These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 3524431

  • 21. Comparative in vitro susceptibilities of 504 bacteremic isolates to ticarcillin plus clavulanic acid and other antimicrobial agents.
    Rotstein C, Amsterdam D, Beam T, Gorzynski E.
    Diagn Microbiol Infect Dis; 1989; 12(2):157-63. PubMed ID: 2752713
    [Abstract] [Full Text] [Related]

  • 22. A comparison of agar dilution, identification of beta-lactamases and disc diffusion methods for assessing the sensitivity to ticarcillin-clavulanic acid.
    Joly B, Chanal M, Sirot D, Cluzel M, Sirot J, Cluzel R.
    J Antimicrob Chemother; 1986 May; 17 Suppl C():27-33. PubMed ID: 3522530
    [Abstract] [Full Text] [Related]

  • 23. [New antimicrobial agent series XXXVII: potassium clavulanate/Ticarcillin sodium].
    Fujimori I.
    Jpn J Antibiot; 1991 Apr; 44(4):365-87. PubMed ID: 1880918
    [No Abstract] [Full Text] [Related]

  • 24. Comparative activities in vitro of timentin (ticarcillin/clavulanic acid) and ureidopenicillins against ampicillin-resistant clinical isolates.
    Griffin KE, Slocombe B.
    J Chemother; 1989 Jul; 1(4 Suppl):267-9. PubMed ID: 16312396
    [No Abstract] [Full Text] [Related]

  • 25. Induction of chromosomal beta-lactamases by different concentrations of clavulanic acid in combination with ticarcillin.
    Stobberingh EE.
    J Antimicrob Chemother; 1988 Jan; 21(1):9-16. PubMed ID: 3128523
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. In-vitro activity of ticarcillin with and without clavulanic acid against clinical isolates of gram-positive and gram-negative bacteria.
    Pulverer G, Peters G, Kunstmann G.
    J Antimicrob Chemother; 1986 May; 17 Suppl C():1-5. PubMed ID: 3636325
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Augmentation effect of clavulanic acid with penicillin, cephalothin and ticarcillin against Bacteroides fragilis.
    Bansal MB, Chuah SK, Oryema-Lalobo M, Thadepalli H.
    Chemotherapy; 1985 May; 31(3):173-7. PubMed ID: 3996086
    [Abstract] [Full Text] [Related]

  • 32. Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid.
    Fuchs PC, Jones RN, Barry AL, Thornsberry C.
    J Clin Microbiol; 1984 Apr; 19(4):555-7. PubMed ID: 6715524
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of clavulanic acid on the activity of ticarcillin against Pseudomonas aeruginosa.
    Tausk F, Stratton CW.
    Antimicrob Agents Chemother; 1986 Oct; 30(4):584-9. PubMed ID: 3098162
    [Abstract] [Full Text] [Related]

  • 38. Timentin versus piperacillin in the treatment of hospitalized patients with urinary tract infections.
    Cox CE.
    J Antimicrob Chemother; 1986 May; 17 Suppl C():93-6. PubMed ID: 3636340
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.